RG
PGEN icon

Redmile Group’s Precigen PGEN Stock Holding History

Redmile Group’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-213,033
Closed -$4.82M – 62
2013
Q3 		$4.82M Buy
+213,033
New +$4.92M 0.73% 38

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group's PGEN Position: Q4 2013 in Review

Redmile Group sold out of Precigen (PGEN) in Q4 2013, closing a stake of 213,033 shares — an estimated $4.82M sold.

Redmile Group first reported a position in PGEN in Q3 2013 and held it in 1 quarter. The position peaked at $4.82M in Q3 2013. 78 funds tracked by Wall St. Rank hold PGEN as of Q4 2013.

  • Redmile Group reported no remaining Precigen position as of Q4 2013 after selling out during the quarter.
  • Redmile Group sold 213,033 Precigen shares in Q4 2013, an estimated $4.82M.
  • Redmile Group first reported a position in Precigen in Q3 2013 and held it in 1 quarter.
  • Redmile Group's Precigen position peaked at $4.82M in Q3 2013.
  • 78 funds tracked by Wall St. Rank held Precigen as of Q4 2013.

Based on Redmile Group's 13F filing for Q4 2013, filed 14 Feb 2014.